Eli Lilly's (LLY) Zepbound Reached All-Time High on TRx and NRx- Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating and $985.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
